Neuromeka Statistics

Total Valuation

Neuromeka has a market cap or net worth of KRW 227.86 billion. The enterprise value is 259.34 billion.

Market Cap	227.86B
Enterprise Value	259.34B

Important Dates

The next estimated earnings date is Tuesday, March 25, 2025.

Earnings Date	Mar 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Neuromeka has 10.55 million shares outstanding. The number of shares has increased by 3.24% in one year.

Current Share Class	n/a
Shares Outstanding	10.55M
Shares Change (YoY)	+3.24%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	21.61%
Owned by Institutions (%)	2.14%
Float	8.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.53
PB Ratio	19.06
P/TBV Ratio	19.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.96
EV / Sales	10.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.41

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of 3.83.

Current Ratio	0.75
Quick Ratio	0.52
Debt / Equity	3.83
Debt / EBITDA	n/a
Debt / FCF	-1.49
Interest Coverage	-4.63

Financial Efficiency

Return on equity (ROE) is -98.02% and return on invested capital (ROIC) is -18.93%.

Return on Equity (ROE)	-98.02%
Return on Assets (ROA)	-15.08%
Return on Capital (ROIC)	-18.93%
Revenue Per Employee	136.17M
Profits Per Employee	-123.91M
Employee Count	175
Asset Turnover	0.26
Inventory Turnover	3.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.75%
50-Day Moving Average	21,390.80
200-Day Moving Average	28,000.90
Relative Strength Index (RSI)	47.61
Average Volume (20 Days)	240,472

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neuromeka had revenue of KRW 23.83 billion and -21.68 billion in losses. Loss per share was -2,389.67.

Revenue	23.83B
Gross Profit	3.58B
Operating Income	-21.71B
Pretax Income	-21.67B
Net Income	-21.68B
EBITDA	-19.67B
EBIT	-21.71B
Loss Per Share	-2,389.67

Full Income Statement

Balance Sheet

The company has 14.32 billion in cash and 45.80 billion in debt, giving a net cash position of -31.48 billion or -2,984.40 per share.

Cash & Cash Equivalents	14.32B
Total Debt	45.80B
Net Cash	-31.48B
Net Cash Per Share	-2,984.40
Equity (Book Value)	11.95B
Book Value Per Share	1,133.10
Working Capital	-12.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -21.75 billion and capital expenditures -9.07 billion, giving a free cash flow of -30.82 billion.

Operating Cash Flow	-21.75B
Capital Expenditures	-9.07B
Free Cash Flow	-30.82B
FCF Per Share	-2,921.51

Full Cash Flow Statement

Margins

Gross margin is 15.03%, with operating and profit margins of -91.11% and -91.00%.

Gross Margin	15.03%
Operating Margin	-91.11%
Pretax Margin	-90.95%
Profit Margin	-91.00%
EBITDA Margin	-82.53%
EBIT Margin	-91.11%
FCF Margin	n/a

Dividends & Yields

Neuromeka does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.24%
Shareholder Yield	-3.24%
Earnings Yield	-11.06%
FCF Yield	-13.53%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neuromeka has an Altman Z-Score of 1.47. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.47
Piotroski F-Score	n/a